Blood Volume is an critical parameter the treatment of several critical diseases such as heart failure, kidney diseases and other illnesses that affect the circulatory system. Clinical evidence suggest that significant improvements exist if blood volume guided treatments are used by medical doctors. The Detalo Clinical™ is being developed as a medical device to be used in normal clinical flow and the use of CO rebreathing makes it available and affordable for use in most medical facilities.
Detalo Clinical™ is under development and is aimed for European market approval during 2022.
Detalo Clinical™ will be certified as a medical device but is not intended to diagnose or treat illnesses. Blood volume measurements are meant to help the treating medical doctor make a better evaluation of patients and support their decision making.